Practice Areas

 

Provides tailor-made support in a wide range of drug development, clinical operations, market access and medical affairs activities

 

 

 

Clinical Development management

  • Portfolio/project evaluation
  • Clinical development plan management for NCE, biosimilars, generics, devices, biomarkers… from early clinical stage to licensing phase and life-cycle management
  • Translational medicine and early clinical research experience 
  • Preclinical requirements: toxicity studies,  animal models and PK, safety pharmacology 
  • All types of phase I : MAD, SAD, ADME, Food effect, TQT, specific populations, Drug Drug interactions, abuse liability, palatability,…
  • Phase II Proof of concept trials design
  • Phase IIB and Phase III trials design,  choice of the endpoints, sample size estimation
  • Strategic scientific positioning : providing strategic direction across therapeutic projects and defining the target product profile
  • Protocol design : writing of the synopsis, selection of essential criteria for determining the safety, efficacy, and medical utilities. Study design and sample size determination
  • Review of data analysis and results presentation

Clinical Operations management

  • Management of clinical operations, pharmacovigilance, and QA : thorough knowledge of clinical trial processes including a strong grasp of international guidelines and regulations (ICH, GCP and EMA, FDA guidances)
  • Selection of CROs, BID defense, budget estimation

Advice for Regulatory Strategy

  • Regulatory strategy and interactions with agencies (EMA, FDA or national agencies)
  •  for all types of process  such IND or CTA,  Advisory meetings, ODD, BTD, NDA or MAA, PSP or PIP, RMP,…

Medical writing

  • Design, drafting or review of all clinical documentation : synopsis, protocols, IB, CTA, IND, CSR, CTD, ISS, ISE, clinical expert reports, Brieffing packages, publications …

Market Access

  • Market access assessment since early development to provide compelling and real-life evidence of a drug’s superior value
  • Early access programs management (compassionate use, ATU, …)
  • Pharmaco economic studies

Medical Affairs

  • Medical affairs activities : shaping product strategy and successfully launching, guaranteeing quality of medical communication in accordance with scientific evidence and commercial strategy
  • Post marketing studies (PASS, observational PMS)

KOLs management

  • Management of Key Opinion Leaders : advisory boards, DSMB, organization of symposia, sites selection, …

Pharmacovigilance

  • Medical monitoring of safety clinical data
  • Review of safety reports : PSURs, DSURs, and other safety related documents
  • Product safety medical review

Business Development

    • Hands-on support for your partnering 
    • Due diligence activities 
    • Licensing opportunities assessment